RSS   Newsletter   Contact   Advertise with us
Post Online Media

Clinigen Group CEO Peter George to step down

ClinigenClinigen Group, a specialty pharmaceuticals business, has been notified by Peter George that he intends to step down as CEO on November 11, 2016.
Article continues below

READ MORE Clinigen Group appoints John Bacon to board

Mr. George will continue as a non executive director. He spent his early career working for the UK’s National Health Service, ending his time there as head of Clinical Pathology in the Oxford region.

Mr. George then brought his expertise to the pharmaceutical industry, holding a number of senior international roles including Executive Vice President for Wolters Kluwer Health, with responsibility for Europe and Asia/Pacific, and Chief Operating Officer for Unilabs Clinical Trials International Limited.

Mr. George’s last role before setting up the Clinigen Group in June 2010 was CEO of Penn Pharma, where he led a management buy-out in 2007.

 LATEST MOVES FROM United Kingdom 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy